Rare diseases
Investigational molecules
Locations
Sindelfinger Strasse 3, Weststadt, 72070 Tuebingen, Germany
Acousia Therapeutics GmbH concentrates its research efforts on developing innovative treatments for hearing disorders and conditions affecting the auditory system. The company's therapeutic portfolio addresses sensorineural hearing loss and related cochlear pathologies, focusing on mechanisms that impact sound perception and auditory function.
The sponsor's development pipeline targets molecular pathways involved in ototoxicity prevention and auditory cell survival, representing a novel approach to treating progressive hearing impairment through pharmaceutical intervention.
Acousia Therapeutics GmbH runs clinical trials in conditions such as Deafness neurosensory, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
